New Perspectives in Pediatric Nonalcoholic Fatty Liver Disease: Epidemiology, Genetics, Diagnosis, and Natural History

키워드

참고문헌 (68)

1. Adams LA, "The natural history of nonalcoholic fatty liver disease : a population-based cohort study", Gastroenterology, 129, pp.113~121 (2005)
2. Anderson EL, "The prevalence of non-alcoholic fatty liver disease in children and adolescents : a systematic review and meta-analysis", PLoS One, 10, pp.e0140908~ (2015)
3. Kim JW, "Prevalence and risk factors of elevated alanine aminotransferase among Korean adolescents: 2001-2014", BMC Public Health, 18, pp.617~ (2018)
4. Young Hoon Choi, "Association Between Vitamin D Deficiency and Suspected Nonalcoholic Fatty Liver Disease in an Adolescent Populatio", Pediatric Gastroenterology, Hepatology & Nutrition, 22(3), pp.233~241 (2019), 대한소아소화기영양학회[DOI]
5. Schwimmer JB, "Prevalence of fatty liver in children and adolescents", Pediatrics, 118, pp.1388~1393 (2006)
6. Guerrero R, "Ethnic differences in hepatic steatosis : an insulin resistance paradox?", Hepatology, 49, pp.791~801 (2009)
7. Schwimmer JB, "Heritability of nonalcoholic fatty liver disease", Gastroenterology, 136, pp.1585~1592 (2009)
8. Romeo S, "Genetic variation in PNPLA3confers susceptibility to nonalcoholic fatty liver disease", Nat Genet, 40, pp.1461~1465 (2008)
9. Koo BK, "Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease", J Gastroenterol Hepatol, 33, pp.1277~1285 (2018)
10. Valenti L, "Homozygosity for the patatin-like phospholipase-3", adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease, 2010, pp.51, 1209~1217
11. Speliotes EK, "PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease", Hepatology, 52, pp.904~912 (2010)
12. Wei JL, "Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients : a population study using proton-magnetic resonance spectroscopy", Am J Gastroenterol, 110, pp.1306~1314 (2015)
13. Romeo S, "The 148M allele of the PNPLA3gene is associated with indices of liver damage early in life", J Hepatol, 53, pp.335~338 (2010)
14. Lin YC, "A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children", J Pediatr, 158, pp.740~744 (2011)
15. Larrieta-Carrasco E, "Association of the I148M", PNPLA3 variant with elevated alanine transaminase levels in normal-weight and overweight, Gene, pp.2013, 520[DOI]
16. Viitasalo A, "Associations of I148M variant in PNPLA3 gene with plasma ALT levels during 2-year follow-up in normal weight and overweight children : the PANIC Study", Pediatr Obes, 10, pp.84~90 (2015)
17. Mangge H, "Patatin-like phospholipase 3(rs738409)gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages", Aliment Pharmacol Ther, 42, pp.99~105 (2015)
18. Kozlitina J, "Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease", Nat Genet, 46, pp.352~356 (2014)
19. Goffredo M, "Role of TM6SF2 rs58542926in the pathogenesis of nonalcoholic pediatric fatty liver disease : A multiethnic study", Hepatology, 63, pp.117~125 (2016)
20. Grandone A, "TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children", Pediatr Obes, 11, pp.115~119 (2016)
21. Zain SM, "Common variant in the glucokinase regulatory gene rs780094 and risk of nonalcoholic fatty liver disease : a meta-analysis", J Gastroenterol Hepatol, 30, pp.21~27 (2015)
22. Goyal NP, "The genetics of pediatric nonalcoholic fatty liver disease", Clin Liver Dis, 22, pp.59~71 (2018)
23. Lin YC, "Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals", Am J Clin Nutr, 99, pp.869~874 (2014)
24. Di Sessa A, "The membrane-bound O-Acyltransferase7 rs641738 variant in pediatric nonalcoholic fatty liver disease", J Pediatr Gastroenterol Nutr, 67, pp.69~74 (2018)
25. Palmer ND, "Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent", Hepatology, 58, pp.966~975 (2013)
26. Tricò D, "Metabolic Features of Nonalcoholic Fatty Liver(NAFL)in obese adolescents : findings from a multiethnic cohort", Hepatology, 68, pp.1376~1390 (2018)
27. Chiara Zusi, "Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents", Digestive and Liver Disease, 51(11), pp.1586~1592 (2019), Elsevier BV[DOI]
28. Stender S, "Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci", Nat Genet, 49, pp.842~847 (2017)
29. Zhu L, "Characterization of gut microbiomes in nonalcoholic steatohepatitis(NASH)patients : a connection between endogenous alcohol and NASH", Hepatology, 57, pp.601~609 (2013)
30. Del Chierico F, "Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach", Hepatology, 65, pp.451~464 (2017)
31. Loomba R, "Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease", Cell Metab, 25, pp.1054~1062.e5 (2017)
32. Schwimmer JB, "Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease", Gastroenterology, 157, pp.1109~1122 (2019)
33. O'Sullivan TA, "Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity", J Pediatr Gastroenterol Nutr, 58, pp.624~631 (2014)
34. Stanhope KL, "Consuming fructosesweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight", obese humans, 2009, pp.119, 1322~1334
35. Malik VS, "Fructose and cardiometabolic health : what the evidence from sugar-sweetened beverages tells us", J Am Coll Cardiol, 66, pp.1615~1624 (2015)
36. Lambert JE, "Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease", Gastroenterology, 146, pp.726~735 (2014)
37. Nobili V, "NAFLD in children : new genes, new diagnostic modalities and new drugs", Nat Rev Gastroenterol Hepatol, 16, pp.517~530 (2019)
38. Schwimmer JB, "Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease", Circulation, 118, pp.277~283 (2008)
39. Donnelly KL, "Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease", J Clin Invest, 115, pp.1343~1351 (2005)
40. Braun HA, "Advances in pediatric fatty liver disease : pathogenesis, diagnosis, and treatment", Gastroenterol Clin North Am, 47, pp.949~968 (2018)
41. Jin R, "Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease", Int J Hepatol, 2014, pp.560620~ (2014)
42. Vos MB, "NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children : recommendations from the Expert Committee on NAFLD(ECON)and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition(NASPGHAN)", J Pediatr Gastroenterol Nutr, 64, pp.319~334 (2017)
43. Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, 41, pp.1313~1321 (2005)
44. Schwimmer JB, "Histopathology of pediatric nonalcoholic fatty liver disease", Hepatology, 42, pp.641~649 (2005)
45. Ko JS, "Clinical and histological features of nonalcoholic fatty liver disease in children", Dig Dis Sci, 54, pp.2225~2230 (2009)
46. Carter-Kent C, "Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease", J Pediatr Gastroenterol Nutr, 52, pp.190~197 (2011)
47. Mansoor S, "The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease", Dig Dis Sci, 60, pp.1440~1447 (2015)
48. Nobili V, "NAFLD in children : a prospective clinical-pathological study and effect of lifestyle advice", Hepatology, 44, pp.458~465 (2006)
49. Manco M, "Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis", Int J Obes(Lond), 32, pp.381~387 (2008)
50. Shannon A, "Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD", J Pediatr Gastroenterol Nutr, 53, pp.190~195 (2011)
51. Noureddin M, "Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials", Hepatology, 58, pp.1930~1940 (2013)
52. Middleton MS, "Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease", Hepatology, 67, pp.858~872 (2018)
53. Yang HR, "Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease", World J Gastroenterol, 18, pp.1525~1530 (2012)
54. Mansoor S, "A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic fatty liver disease", Curr Gastroenterol Rep, 17, pp.23~ (2015)
55. Nobili V, "Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis", Hepatology, 48, pp.442~448 (2008)
56. Lee CK, "Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort : the Boston children's hospital experience", J Pediatr, 163, pp.1058~1064.e2 (2013)
57. Garcovich M, "Liver stiffness in pediatric patients with fatty liver disease : diagnostic accuracy and reproducibility of shear-wave elastography", Radiology, 283, pp.820~827 (2017)
58. Etchell E, "Liver stiffness values are lower in pediatric subjects than in adults and increase with age : a multifrequency MR elastography study", Radiology, 283, pp.222~230 (2017)
59. Schwimmer JB, "Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease", Hepatology, 66, pp.1474~1485 (2017)
60. Xiao G, "Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease : A meta-analysis", Hepatology, 66, pp.1486~1501 (2017)
61. Angulo P, "Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease", Gastroenterology, 149, pp.389~397.e10 (2015)
62. Holterman AX, "Nonalcoholic fatty liver disease in severely obese adolescent and adult patients", Obesity(Silver Spring), 21, pp.591~597 (2013)
63. A-kader H, "Nonalcoholic fatty liver disease in children : a single center experience", Clin Gastroenterol Hepatol, 6, pp.799~802 (2008)
64. Lavine JE, "Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents : the TONIC randomized controlled trial", JAMA, 305, pp.1659~1668 (2011)
65. Nobili V, "Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease : a randomized, controlled trial", Hepatology, 48, pp.119~128 (2008)
66. Cioffi CE, "Natural history of NAFLD diagnosed in childhood: a single-center study", Children(Basel), 4, pp.E34~ (2017)
67. Feldstein AE, "The natural history of non-alcoholic fatty liver disease in children : a follow-up study for up to 20 years", Gut, 58, pp.1538~1544 (2009)
68. Goyal NP, "The Progression and natural history of pediatric nonalcoholic fatty liver disease", Clin Liver Dis, 20, pp.325~338 (2016)

관련 논문AI추천